Health

The First International Conference On Single-Cell And Spatial Omics is held in Guangzhou, China: the Golden Age of Single Cell Analysis

GUANGZHOU, China, May 8, 2023 /PRNewswire/ -- On April 16th 2023, the first International Conference on Single-cell and Spatial Omics (TICSSO-1) has come to a grand conclusion. The conference brings together on site over 2,000 professionals from academia, research and development, investment and ...

2023-05-09 12:27 1770

TCI won three prizes in the 2023 Green World Awards, revealing new technologies at Vitafoods Europe

TAIPEI, May 8, 2023 /PRNewswire/ -- Another good news from TCI! TCI won three prizes in Green World Awards organized by the Green Organisation, namely "Green World Champion for Upcycling Economy," "Global Gold Winner for Biodiversity," and "Global Silver Winner for Corporate Sustainability." Winn...

2023-05-09 10:36 1929

Online Competition Platform PitPat Has Launched an Environmentally-themed Competition

HOUSTON, May 8, 2023 /PRNewswire/ -- The PitPat theme competition, which is usually held on major anniversaries, was designed to make users more environmentally aware. PitPat, an online competition platform based in Houston, announced that the Arbor Day Challenge will be held fromMay 6 to May 9....

2023-05-08 23:30 2101

Singlera Genomics Receives FDA Breakthrough Device Designation for PDACatch, a Liquid Biopsy Assay for Pancreatic Cancer Detection in High-Risk Individuals

SAN DIEGO, May 8, 2023 /PRNewswire/ -- Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, today announced that it had received Breakthrough Device Designation from the Food and Drug Administration (FDA) for its PDACatch assay, a nov...

2023-05-08 22:00 1771

EmeTerm Anti Fatigue & Car Sickness Wristband Wins the IF and IDA Design Awards

VANCOUVER, BC, May 8, 2023 /PRNewswire/ -- Improving the driving experience of drivers and passengers has been one of the directions of innovation in the automotive industry for many years. To address motion sickness and driving fatigue, automakers are working to develop a variety of technologies...

2023-05-08 21:00 2171

PharmAbcine to participate in "BIO International Convention 2023"

DAEJEON, South Korea, May 8, 2023 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company will participate in the upcoming BIO International Convention 2023. Details...

2023-05-08 20:00 2119

Chance Pharmaceuticals and Acorda Therapeutics Announce Agreement to Provide INBRIJA® in Greater China

HANGZHOU, China, May 8, 2023 /PRNewswire/ -- Chance Pharmaceuticals and Acorda Therapeutics, Inc. today announced that they have entered into distribution and supply agreements to provide INBRIJA® in Greater China (Mainland China, Taiwan, Hong Kong, and Macao). INBRIJA is indicated in the United ...

2023-05-08 19:30 1659

Biosion Presents Discovery and Development Data at PEGS for its Anti-CD40 Agonistic Antibody

NEWARK, Del. and NANJING, China, May 8, 2023 /PRNewswire/ -- Biosion USA, Inc. (Biosion), a global R&D biotechnology company, today announced the upcoming presentation of discovery and development data for BSI-038, an anti-CD40 agonistic antibody at the PEGS Boston conference to be held from May ...

2023-05-08 19:30 1704

MEDICAL IP Is Creating Medical Digital Twins in Virtual Spaces, Powered by NVIDIA Omniverse

* MEDIP PRO, a real-time digital twin implementation solution based on medical imaging, is now connected to NVIDIA Omniverse * Maximize medical data scalability by sharing and simulating medical-imaging-based digital twins without time and space limitations SEOUL, South Korea and SANTA CLARA,...

2023-05-08 16:00 2074

Neuro3 Therapeutics Acquires Exclusive Worldwide Rights to Develop and Commercialize Clinical Stage KCNQ2 Activators from Lundbeck

CAMBRIDGE, Mass. and SUZHOU, China, May 8, 2023 /PRNewswire/ -- Neuro3 Therapeutics (Neuro3), a biotechnology company focused on the discovery and development of innovative medicines for the treatment of central nervous system (CNS) diseases, announced today the signing of an exclusive, worldwide...

2023-05-08 14:00 1712

BLISS BIOPHARMACEUTICAL ENTERS INTO A CLINICAL TRIAL COLLABORATION AGREEMENT WITH AN OPTION OF STRATEGIC COLLABORATION WITH EISAI FOR BB-1701

HANGZHOU, China, May 7, 2023 /PRNewswire/ -- Bliss Biopharmaceutical (Hangzhou) Co., Ltd, ("BlissBio") a clinical-stage biopharmaceutical company developing differentiated antibody-drug conjugate (ADC) therapeutics, announced a clinical trial collaboration agreement with option for strategic coll...

2023-05-08 07:00 2292

NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE

* Singapore's Health Sciences Authority (HSA) has approved QINLOCK® (ripretinib) for the treatment of patients with 4th line GIST * QINLOCK significantly reduced the risk of disease progression or death by 85% and showed clinically meaningful overall survival in theINVICTUS Phase 3 Study1,2 ...

2023-05-08 04:00 2001

Suzhou GenAssist Therapeutic Co.,Ltd recently announced that its first base editing product, GEN6050, has submitted a pre-IND application to the FDA and has been accepted

SUZHOU, China, May 6, 2023 /PRNewswire/ -- Suzhou GenAssist Therapeutic Co.,Ltd recently announced its pre-IND application of their first base editing product, GEN6050 and the acceptance by the FDA.   GEN6050 is an in vivo base editing drug that targets exon 50 skipping in the Duchenne muscular...

2023-05-06 21:00 4766

Empowering Innovation to the Global Market with Acro Certify

NEWARK, Del., May 5, 2023 /PRNewswire/ -- For many companies, entering the global market is a daunting challenge. These obstacles can come in various forms. Sometimes the problem is finding the right target customer base or establishing an appropriate quality management system and shipping logist...

2023-05-06 10:18 4923

Vice President of Tencent HealthCare Zhang Yu: Create the "flywheel" of software development effectiveness and efficiency to drive continuous innovation in healthcare

BEIJING, May 5, 2023 /PRNewswire/ -- The digital era has ushered rapid changes in software development philosophy and process, as well as technologies and tools. For healthcare, the digital transformation of the industry allows for rapid response to major public health emergencies, stable operati...

2023-05-05 21:10 2537

CARsgen's CLDN18.2 mAb AB011 Achieves IND Clearance from the NMPA for the First-line Combination Treatment of Gastric Cancer

SHANGHAI, May 5, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced that AB011 in combination with atezolizumab monoclonal antibody, Roche'...

2023-05-05 20:50 3372

Health In Tech Revolutionizes Level-Funded Health Plans in Ohio through Partnership with Ohio PPO Connect

STUART, Fla., May 5, 2023 /PRNewswire/ -- Health in Tech, the industry-leading insurtech company that delivers disruptive innovation and reimagines self-funded health plans, proudly announces its accelerated implementation with Ohio PPO Connect, LLC. This strategic partnership aims to provide a ...

2023-05-05 20:30 2451

ProQure and Identiv Partner to Launch Innovative NFC Type 2 Tags for Large-Scale NFC Deployments

The partnership's new PQ201/201s series tags deliver premium features at a competitive price point PLEASANTON, Calif., May 5, 2023 /PRNewswire/ -- ProQure, a technology provider of IoT cloud management for physical objects, and Identiv, a global leader in physical security and secure identificat...

2023-05-05 18:00 2509

Arbele celebrates its 7th anniversary as a clinical-stage immunotherapy biotech and the opening of TibTech, its cancer diagnostics subsidiary

SEATTLE, May 5, 2023 /PRNewswire/ -- Arbele, a biotechnology company dedicated to fighting gastrointestinal cancers, celebrates its 7th anniversary and the opening of Tiberias Technology (TibTech), its accredited lab for cancer screening and in vitro diagnostics, at the Hong Kong Science and Tech...

2023-05-05 15:00 1819

Formosa Pharmaceuticals and AimMax Therapeutics Announce the NDA Submission to the US FDA for APP13007 for the Treatment of Post-Operative Inflammation and Pain following Ocular Surgery

TAIPEI, May 4, 2023 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (6838.TWO) and AimMax Therapeutics, Inc. (United States) announce the submission of a New Drug Application to the United States Food & Drug Administration (US FDA) for APP13007, a novel aqueous nanosuspension formulation of the pot...

2023-05-05 08:00 1997
1 ... 9899100101102103104 ... 280